Skip to content

The effect of vitamin D on depression in the elderly

The effect of vitamin D on depression in the elderly population in Kashan, Iran in 2016

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT2016042527587N1
Enrollment
60
Registered
2016-07-04
Start date
2016-03-01
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Depression. Mental and behavioral disorders

Interventions

Intervention 1: Patients in the intervention group for 8 weeks of 50,000 IU vitamin capsules will be administered one capsule per week. Intervention 2: In the control group taking a placebo with the s
Treatment - Drugs
Placebo
Patients in the intervention group for 8 weeks of 50,000 IU vitamin capsules will be administered one capsule per week.
In the control group taking a placebo with the same statement prepared by the pharmaceutical company producing the drug is used.

Sponsors

Kashan University of Medical Sciences & Research Department
Lead Sponsor

Eligibility

Sex/Gender
All
Age
60 Years to 80 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: 1. Iranian citizenship; 2. Age older than 60 years old; 3. The ability to speak in Farsi, and answering questions; 4. Lack of mental retardation; 5. Not using vitamin D; 6. No disability ;7. No history of mental illness other than depression. Exclusion criteria: 1. Uncooperative and refused further treatment and vitamin D patients in the intervention group; 2. Vitamin D administration in control group; 3. The occurrence of any severe stress, such as hospitalization or death of relatives in both groups during the study.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Depression. Timepoint: Before and two months after intervention. Method of measurement: Geriatric Depression Scale.

Secondary

MeasureTime frame
Vitamin D in blood. Timepoint: before intervention and 2 months after. Method of measurement: blood test.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Negin Masoudi Alavi

Kashan University of Medical Sciences

masudialavi_N@kaums.ac.ir+98 31 5554 6633

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026